Saarum Sciences | OncoPrime – Breast Cancer

Use a primary cell-based platform that truly represents the clinical diversity of breast cancer – Switch to OncoPrime – Breast Cancer

Based on biomarker expression breast cancer can be categorized into four major subtypes. Triple negative (TNBC) tumors respond best to chemotherapy similar to other aggressive cancers. Luminal A tumors respond best to endocrine therapy e.g. antiestrogen or aromatase inhibitor

Diversity of samples available in the biobank. With steady inflow of patient
samples, we have banked a generous diversity of Breast cancer samples. The chart represents high level categories only. Breast cancer staging as per WHO guidelines.